Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN) will release its second quarter 2026 financial results after the market close on Thursday, July 30, 2026, followed by an earnings conference call at 4:30 p.m. ET. Management will discuss the company’s financial overview and business performance, with live and archived access available via the Investor Relations website.

News Market Reaction – MYGN

+0.71%

+0.71% News Effect

On the day this news was published, MYGN gained 0.71%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Recent Form 4 activity was classified as Net Selling, providing a platform-level counterpoint as MYG...

Analysis

Recent Form 4 activity was classified as Net Selling, providing a platform-level counterpoint as MYGN schedules its Q2 2026 results. The active, not-yet-effective S-3 registration and mixed earnings-date history are relevant risks to monitor.

Key Figures

Reporting Period: Q2 2026 Release Date: July 30, 2026 Conference Call Time: 4:30 pm ET

3 metrics

Reporting Period Q2 2026 Financial results

Release Date July 30, 2026 After market close

Conference Call Time 4:30 pm ET July 30, 2026

Previous Earnings date Reports

2 past events · Latest: Apr 28 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 28	Earnings date	Neutral	-3.3%	Scheduled Q1 2026 results release and 4:30 p.m. ET conference call.
Feb 16	Earnings date	Neutral	+0.2%	Scheduled Q4 and FY2025 results release with conference call and webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two tag-matched earnings-date events showed mixed 24-hour reactions: -3.31% and +0.22%, rather than a consistent direction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, July 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2026 earnings conference call at 4:30 pm ET on Thursday, July 30, 2026. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the second quarter of 2026.

A live webcast of the conference call can be accessed on Myriad’s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at investor.myriad.com following the call.

About Myriad Genetics 
Myriad Genetics is a leading molecular diagnostic and precision medicine company committed to advancing health and well-being for all. Myriad Genetics develops and commercializes molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare costs. For more information, visit myriad.com.

Investor Contact 
Matt Scalo 
(801) 584-3532 
IR@myriad.com 

Media Contact 
Andria Rosell
(385) 202-3510
PR@myriad.com

FAQ

When will Myriad Genetics (NASDAQ: MYGN) release its Q2 2026 earnings?

Myriad Genetics will release its second quarter 2026 earnings on July 30, 2026, after the market closes. According to Myriad Genetics, the release will be followed by a management conference call and webcast that same afternoon.

What time is the Myriad Genetics Q2 2026 earnings conference call on July 30, 2026?

The Myriad Genetics Q2 2026 earnings conference call is scheduled for 4:30 p.m. ET on July 30, 2026. According to Myriad Genetics, management will provide a financial overview and business update for the quarter.

How can investors access the Myriad Genetics (MYGN) Q2 2026 earnings webcast?

Investors can access the live Q2 2026 earnings webcast on Myriad Genetics’ Investor Relations website at investor.myriad.com. According to Myriad Genetics, an archived webcast will also be available on the same site following the call.

How do I join the Myriad Genetics Q2 2026 earnings call by telephone?

To join by telephone, participants must register online in advance. According to Myriad Genetics, registration will provide a dial-in number and a unique PIN required to access the live conference call on July 30, 2026.

Will a replay of the Myriad Genetics (MYGN) Q2 2026 earnings call be available?

Yes, a replay of the Q2 2026 earnings call will be available as an archived webcast at investor.myriad.com. According to Myriad Genetics, investors can access the recording on the Investor Relations website after the live call concludes.